Invesco Comstock Fund
AIM Sector Funds (Invesco Sector Funds) · 6 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Invesco Comstock Fund is an actively managed U.S. equity fund. 1% of ACSTX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 90% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q3
The Funds investment objective is total return through growth of capital and current income.
The fund invests at least 80% of assets in common stocks, emphasizing large-capitalization issuers, with a value-oriented approach that seeks undervalued, well-established companies expected to improve in valuation. It may allocate up to 25% to foreign securities including emerging markets, up to 10% to REITs, and uses derivatives including futures and currency forwards for exposure and hedging. The fund's returns depend on the portfolio managers' security selection and timing decisions.
| Share class | Expense ratio |
|---|---|
| ACSTX | 0.80% |
| ACSYX | 1.52% |
| ACSDX | 0.55% |
| ACSHX | 0.51% |
| ACSRX | 1.05% |
| ICSFX | 0.44% |
Portfolio turnover 26.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 95.13% |
| Cash & short-term | 6.13% |
| Derivatives | -0.01% |
Look-through blends 1 underlying fund; 0.0% of NAV was not looked through and stays direct-classified.
The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Financials | 18.3% |
| Health Care | 14.6% |
| Industrials | 12.1% |
| Information Technology | 10.3% |
| 10 smaller | 44.8% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Largest new: Reckitt Benckiser Group PLC, DVN, Anheuser-Busch InBev S.A./N.V., AstraZeneca PLC, Tenaris S.A., Novo Nordisk A/S, INVH, OXY
Exited: SYY, Reckitt Benckiser Group PLC, AstraZeneca PLC, Anheuser-Busch InBev S.A./N.V., BMY, Tenaris S.A., KMB, Universal Music Group N.V.
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +27.71% | +59.84% | +80.90% | 10.43% | -8.82% | |
| +26.79% | +56.38% | +74.40% | 10.45% | -8.97% | |
| +28.05% | +61.03% | +83.20% | 10.45% | -8.76% | |
| +28.14% | +61.25% | +83.66% | 10.44% | -8.76% | |
| +27.42% | +58.67% | +78.69% | 10.47% | -8.88% | |
| +28.21% | +61.63% | +84.29% | 10.47% | -8.76% |
These classes hold the same portfolio, so the 9.90pp spread over 5 years is the cost difference between them — roughly 1.98pp a year — not a difference in what they own.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| GOOGL | Alphabet Inc.GOOGL | 4.08% | $384.80 | $585.40M | 1.5M |
| BAC | Bank of America Corp.BAC | 3.38% | $53.46 | $485.03M | 9.1M |
| TRPXX | Invesco Treasury PortfolioTRPXX | 3.13% | — | $448.69M | — |
| CVS | CVS Health Corp.CVS | 2.55% | $83.29 | $366.12M | 4.4M |
| MSFT | Microsoft Corp.MSFT | 2.46% | $407.78 | $353.49M | 866.9K |
| CSCO | Cisco Systems, Inc.CSCO | 2.40% | $91.50 | $344.86M | 3.8M |
| WFC | Wells Fargo & Co.WFC | 2.29% | $82.23 | $328.24M | 4.0M |
| CVX | Chevron Corp.CVX | 2.15% | $193.31 | $309.18M | 1.6M |
| STT | State Street Corp.STT | 1.97% | $152.84 | $282.71M | 1.8M |
| MRK | Merck & Co., Inc.MRK | 1.95% | $109.18 | $279.38M | 2.6M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.
Top 10 positions are 26.36% of net assets, top 25 51.45%, across 84 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free